tradingkey.logo
搜索

LENSAR Inc

LNSR
添加自选
5.010USD
-0.160-3.09%
收盘 07-31 16:00美东报价延迟15分钟
60.63M总市值
2.05市盈率 TTM

关于 LENSAR Inc 公司

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

LENSAR Inc简介

公司代码LNSR
公司名称LENSAR Inc
上市日期Sep 21, 2020
CEOCurtis (Nicholas T)
员工数量140
证券类型Ordinary Share
年结日Sep 21
公司地址2800 Discovery Drive
城市ORLANDO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32826
电话18885367271
网址https://www.lensar.com/
公司代码LNSR
上市日期Sep 21, 2020
CEOCurtis (Nicholas T)

LENSAR Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
--
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
--
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
--
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Thomas R. Staab, II
Mr. Thomas R. Staab, II
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Ms. Elizabeth G. O'Farrell
Ms. Elizabeth G. O'Farrell
Independent Director
Independent Director
--
--
Mr. Thomas B. Ellis
Mr. Thomas B. Ellis
Independent Director
Independent Director
--
--
Mr. Todd B. Hammer
Mr. Todd B. Hammer
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Nicholas T. (Nick) Curtis
Mr. Nicholas T. (Nick) Curtis
Chief Executive Officer, Director
Chief Executive Officer, Director
855.10K
--
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
550.64K
--
Dr. Richard L. Lindstrom, M.D.
Dr. Richard L. Lindstrom, M.D.
Independent Director
Independent Director
246.41K
--
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
92.95K
--
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
88.21K
--
Mr. Alan B. Connaughton
Mr. Alan B. Connaughton
Chief Operating Officer
Chief Operating Officer
--
--

常见问题

LENSAR Inc的前五大股东是谁?

LENSAR Inc 的前五大股东如下:Mr. Nicholas T. (Nick) Curtis

有多少机构持有LENSAR Inc(LNSR)的股份?

截至2026Q1,共有172家机构持有LENSAR Inc的股份,合计持有的股份价值约为6.68M,占公司总股份的55.41%。与2025Q4相比,机构持股有所增加,增幅为-342758.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有